Canada Pension Plan Investment Board Purchases New Holdings in CVS Health Corporation $CVS

Canada Pension Plan Investment Board acquired a new position in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 2,229,244 shares of the pharmacy operator’s stock, valued at approximately $230,615,000.

A number of other hedge funds have also made changes to their positions in CVS. Kilter Group LLC acquired a new stake in shares of CVS Health in the second quarter valued at about $27,000. Beaird Harris Wealth Management LLC grew its stake in CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 195 shares in the last quarter. J.Safra Asset Management Corp acquired a new stake in CVS Health in the 2nd quarter valued at about $30,000. Dunhill Financial LLC purchased a new position in CVS Health in the 2nd quarter worth approximately $32,000. Finally, Swiss RE Ltd. acquired a new position in shares of CVS Health during the 4th quarter worth approximately $26,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS Health stock opened at $92.95 on Wednesday. The firm has a market cap of $118.88 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 0.86 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The business’s fifty day simple moving average is $101.73 and its 200-day simple moving average is $89.20.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same period in the previous year, the firm earned $1.81 EPS. CVS Health’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio is currently 70.37%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on CVS shares. Mizuho increased their price target on CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Barclays upped their target price on CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Morgan Stanley lifted their price target on CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a report on Thursday, June 4th. Wells Fargo & Company boosted their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.